ASND Kapitalisasi Akuntansi Ascendis Pharma

Logo perusahaan publik Ascendis Pharma (ASND)

This daily price chart for Ascendis Pharma A/S (ASND) reflects the performance of a company developing long-acting medications to treat rare hormonal pathologies. The operating model relies on external contractors for final testing and commercial launch, which reduces development costs to 1.63. The business is based on proprietary delivery methods that provide robust protection against replication and enable the company to effectively compete with industry behemoths.

ASND Kapitalisasi Buku Ascendis (04.07.2022 - 27.10.2026)

Rincian metrik lan analitis perusahaan Ascendis Pharma (ASND)

- rega lan prakiraan konsensus rega:
Kurs saham Ascendis|ASND - Prakiraan konsensus analis
- data kapitalisasi pasar:
Kapitalisasi pasar Ascendis Pharma AS|ASND - Nilai Total Perusahaan
- data kapitalisasi buku:
Nilai Buku Saham Ascendis Pharma|ASND - Kapitalisasi Buku|Nilai Pasar marang Nilai Buku ascendispharma.com|ASND - Total Aset Perusahaan
- data utang lan likuiditas:
Total Utang marang Modal Ascendis Pharma A/S|ASND - Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal Ascendis Pharma AS|ASND - Utang perusahaan|Utang marang nilai buku Ascendis Pharma AS
Pambiji fundamental:ASND - Ascendis
Barang unggulan Ascendis Pharma AS

Book value capitalization reflects the total value of net assets, excluding the impact of market speculation. This indicator allows an investor to strip away price volatility by focusing on the business's actual capital. By analyzing the book value trend of a company, one can determine the true stability of its fundamental value. For Ascendis Pharma A/S (ASND), this growth confirms the effectiveness of investments in bioethical developments. Supply chain optimization and ESG standards directly strengthen the company's tangible asset base.

Analisis pesaing Ascendis Pharma A/S

MDGL - Kapitalisasi Akuntansi|Kapitalisasi Buku Corcept Therapeutics|RYTM (rhythmtx.com) - Kapitalisasi Akuntansi|Nilai Buku Perusahaan Akero AKRO|Nilai Aset Bersih Metsera, Inc.|MoonLake Pharma (MLTX) - Kapitalisasi Buku|Nilai Akuntansi Perusahaan Crinetics Corp (CRNX)|Kapitalisasi Buku NAMS (NewAmsterdam Pharma)|soleno.life - Kapitalisasi Buku|Nilai Buku Perusahaan Amicus Therapeutics, Inc. (FOLD)|ETNB: Nilai Akuntansi Perusahaan|AGIO (Agios Pharmaceuticals Inc) - Nilai Buku Perusahaan|Structure Corp (GPCR) - Aset Bersih Perusahaan|MDXG (MiMedx Group, Inc.) - Kapitalisasi Buku|Kapitalisasi Buku rezolutebio.com (RZLT)|Lexicon Pharmaceuticals, Inc. (LXRX) - Aset Bersih Perusahaan|Nilai Akuntansi Perusahaan MBX (MBX Biosciences, Inc.)|Altimmune Corp - Nilai Buku Perusahaan|Aset Bersih Perusahaan Aardvark Pharma AARD|SGMT (Sagimet Biosciences) - Kapitalisasi Buku|bioagelabs.com (BIOA) - Ekuitas Perusahaan|BMEA - Aset Bersih Perusahaan|Quince Therapeutics, Inc. (QNCX) - Total Aset Bersih|GUTS (Fractyl) - Kapitalisasi Buku|Kapitalisasi Buku vTv Therapeutics Inc|Kapitalisasi Buku Agape ATP Corporation (ATPC)|Nilai Buku Perusahaan PLUR (pluri-biotech.com)|SYBX: Nilai Buku Perusahaan|Lipocine Inc - Ekuitas Perusahaan|MTNB - Nilai Buku Perusahaan|SPRB - Nilai Buku Perusahaan|Galecto, Inc. - Kapitalisasi Buku|CTCX (carmellrx.com) - Pambiji Buku Bisnis|LUMO: Nilai Buku Perusahaan|Pambiji Buku Bisnis ONVO|Nilai Buku Perusahaan RDUS (Radius Health)